Genfit raises €16.0M Series B round
18 September 2019· Loos, France· health, biotech, drug_development, diagnostics, b2b
Versantis had raised equity funding to advance its programs, with the lead program, VS-01, due to enter a Phase IIa proof-of-concept trial.
About Genfit
Stage
Series B
Headquarters
Loos, France
Founded
1999
Team Size
51–200
Sectors
healthbiotechdrug_developmentdiagnosticsb2b